logo for Alkermes

Alkermes

Business Services · Ireland · 2,100 Employees

View Company Info for Free

About

Headquarters

Connaught House 1 Burlington Rd, Dublin, Dublin...

Phone Number

+353 17728000

Revenue

$1.5 Billion

Stock Symbol

ALKS

Industry

Business Services General Business Services

Most Recent Scoops

Oct 31 2024
Left Company
Oct 21 2024
Open Position
See all scoops

Highlights

$251.2M

Total Funding Amount

-

Most Recent Funding Amount

3

Number of Funding Rounds

View details

Who is Alkermes

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.Read more
Alkermes's Social MediaPopular SearchesAlkermes IncAlkermesAlkermes PLCAlkermes Controlled Therapeutics IncAlkermes Gainesville LLCSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: ALKSShow more

Alkermes Org Chart

Richard Pops

Chairman & Chief Executive Officer

PhoneEmail
Blair Jackson

Executive Vice President & Chief Operating Of...

PhoneEmail
Iain Brown

Senior Vice President, Chief Financial Office...

PhoneEmail

PhoneEmail

Is Alkermes your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Alkermes

Compare insights from companies similar to Alkermes, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Alkermes

$1.5B
2.1K
Richard Pops Top Executive
$3.1B
5.7K
Placeholder for Top Executive
$2B
3.0K
Placeholder for Top Executive
$1.4B
5K
Placeholder for Top Executive
$758.5M
2.1K
Placeholder for Top Executive

Compare CEO

How does Richard Pops compare against Competing Companies' CEOs?

Richard Pops
Richard Pops

Chairman & Chief Executive Officer at Alkerme...

Top 25%

CEO effectiveness to drive business results

Excellent
50%
Good
50%
Average
0%
Poor
0%
Very Bad
0%
CEO management style
Good
50%
Bad
50%

VS.

Tassos Gianakakos

Tassos Gianakakos

CEO at MyoKardia

CEO effectiveness to drive business results

Excellent
100%
Good
0%
Average
0%
Poor
0%
Very Bad
0%
CEO management style
Good
100%
Bad
0%
Illustration of an envelope

Alkermes financials insights

Gather financial insights about Alkermes, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Alkermes Employee Growth Rate

Graph showing projected employee growth data for Alkermes

View Alkermes’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Alkermes Tech Stack

A closer look at the technologies used by Alkermes

Most Recent Scoops

Oct 31 2024
Left Company
Executive Moves, Left Company
Oct 23 2024
Hiring Plans
Hiring Plans
Oct 21 2024
Open Position
Oct 21 2024
Open Position
Sep 12 2024
Award
Award, Employee Engagement, Employee Relations, Employee Retention, Workforce Management, Bioengineering, Pharmaceuticals, Company Culture & Policy, Diversity & Inclusion, HR Operations, Operations, Organizational Development, Talent Management
See more scoops

Alkermes News & Media

Read more news

Frequently Asked Questions Regarding Alkermes

Where is Alkermes located?
Alkermes's headquarters are located at Connaught House 1 Burlington Rd, Dublin, Dublin City, D04 C5Y6, Ireland
What is Alkermes's phone number?
Alkermes's phone number is +353 17728000
What is Alkermes's stock symbol?
Alkermes's stock symbol is ALKS
What is Alkermes's official website?
Alkermes's official website is www.alkermes.com
What is Alkermes's Revenue?
Alkermes's revenue is $1.5 Billion
What is Alkermes's SIC code?
Alkermes's SIC: 87,873
What is Alkermes's NAICS code?
Alkermes's NAICS: 54,541
How many employees does Alkermes have?
Alkermes has 2,100 employees
What industry does Alkermes belong to?
Alkermes is in the industry of: Business Services General, Business Services
What is Alkermes competition?
Alkermes top competitors include: Alexion, Jazz Pharmaceuticals, Neurocrine Biosciences, Lundbeck
What companies has Alkermes acquired?
Alkermes has acquired the companies: Rodin
What technology does Alkermes use?
Some of the popular technologies that Alkermes uses are: DocuSign, Drupal, reCAPTCHA, PHP
Who is the CEO of Alkermes?
Alkermes's CEO is Richard Pops
Who is the CFO of Alkermes?
Alkermes's CFO is Iain Brown
How do I contact Alkermes?
Alkermes contact info: Phone number: +353 17728000 Website: www.alkermes.com
What does Alkermes do?

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophreni... a and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.Read More

What are Alkermes social media links?
Alkermes Linkedin page Alkermes Twitter page Alkermes Facebook page
How much funding has Alkermes raised to date?
Alkermes has raised $251.2 Million in 3 funding rounds
Who invested in Alkermes?
Alkermes has 3 investors including Primecap Management and Invesco.
Is Alkermes a public company?
Yes, Alkermes is a public company and is traded under the symbol ALKS
See more information about Alkermes

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.